Hexavest’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | $17.6M | Sell |
410,098
-202,419
| -33% | -$8.97M | 1.08% | 23 |
|
|
2021
Q2 | $24M | Buy |
612,517
+101,784
| +20% | +$3.96M | 1.19% | 18 |
|
|
2021
Q1 | $18.5M | Sell |
510,733
-32,209
| -6% | -$1.14M | 0.82% | 32 |
|
|
2020
Q4 | $20M | Sell |
542,942
-858,942
| -61% | -$31.5M | 0.75% | 36 |
|
|
2020
Q3 | $48.8M | Sell |
1,401,884
-309,580
| -18% | -$10.9M | 1.31% | 11 |
|
|
2020
Q2 | $53.1M | Sell |
1,711,464
-642,168
| -27% | -$21.8M | 1.23% | 17 |
|
|
2020
Q1 | $72.9M | Buy |
2,353,632
+83,101
| +4% | +$2.83M | 1.27% | 11 |
|
|
2019
Q4 | $84.4M | Sell |
2,270,531
-569,915
| -20% | -$20.3M | 1.03% | 23 |
|
|
2019
Q3 | $96.8M | Sell |
2,840,446
-107,415
| -4% | -$3.91M | 1.3% | 16 |
|
|
2019
Q2 | $121M | Sell |
2,947,861
-376,196
| -11% | -$14.9M | 1.6% | 12 |
|
|
2019
Q1 | $134M | Sell |
3,324,057
-1,937,969
| -37% | -$77.6M | 1.7% | 10 |
|
|
2018
Q4 | $218M | Sell |
5,262,026
-514,656
| -9% | -$21.4M | 3.17% | 4 |
|
|
2018
Q3 | $242M | Sell |
5,776,682
-524,887
| -8% | -$20.2M | 3.09% | 3 |
|
|
2018
Q2 | $217M | Sell |
6,301,569
-904,642
| -13% | -$30.9M | 2.8% | 5 |
|
|
2018
Q1 | $243M | Sell |
7,206,211
-95,730
| -1% | -$3.29M | 3.03% | 4 |
|
|
2017
Q4 | $251M | Buy |
7,301,941
+136,157
| +2% | +$4.64M | 2.86% | 5 |
|
|
2017
Q3 | $243M | Buy |
7,165,784
+190,602
| +3% | +$6.13M | 2.97% | 4 |
|
|
2017
Q2 | $222M | Sell |
6,975,182
-269,317
| -4% | -$8.49M | 2.89% | 3 |
|
|
2017
Q1 | $235M | Buy |
7,244,499
+356,238
| +5% | +$11.2M | 2.8% | 3 |
|
|
2016
Q4 | $212M | Buy |
6,888,261
+1,319,747
| +24% | +$40.3M | 2.91% | 2 |
|
|
2016
Q3 | $179M | Sell |
5,568,514
-516,459
| -8% | -$17.3M | 3.05% | 2 |
|
|
2016
Q2 | $203M | Sell |
6,084,973
-440,685
| -7% | -$14.1M | 3.08% | 1 |
|
|
2016
Q1 | $184M | Sell |
6,525,658
-93,864
| -1% | -$2.68M | 2.73% | 5 |
|
|
2015
Q4 | $203M | Buy |
6,619,522
+825,189
| +14% | +$26M | 3.21% | 3 |
|
|
2015
Q3 | $173M | Buy |
5,794,333
+211,537
| +4% | +$6.78M | 3.02% | 2 |
|
|
2015
Q2 | $178M | Sell |
5,582,796
-186,489
| -3% | -$6.08M | 2.96% | 1 |
|
|
2015
Q1 | $190M | Sell |
5,769,285
-272,988
| -5% | -$8.68M | 3.02% | 2 |
|
|
2014
Q4 | $179M | Buy |
6,042,273
+23,772
| +0.4% | +$682K | 2.67% | 5 |
|
|
2014
Q3 | $169M | Buy |
6,018,501
+914,423
| +18% | +$25.7M | 2.57% | 5 |
|
|
2014
Q2 | $144M | Buy |
5,104,078
+96,083
| +2% | +$2.74M | 2.15% | 10 |
|
|
2014
Q1 | $153M | Sell |
5,007,995
-70,696
| -1% | -$2.11M | 2.38% | 6 |
|
|
2013
Q4 | $148M | Sell |
5,078,691
-4,184
| -0.1% | -$122K | 2.26% | 6 |
|
|
2013
Q3 | $138M | Buy |
5,082,875
+59,627
| +1% | +$1.62M | 2.08% | 4 |
|
|
2013
Q2 | $133M | Buy |
+5,023,248
| New | +$139M | 2.27% | 3 |
|
Other funds holding PFE
Hexavest's PFE Position: Q3 2021 in Review
Hexavest reduced its Pfizer (PFE) stake by 33% in Q3 2021, selling an estimated $8.97M and leaving 410,098 shares worth $17.6M. The position accounts for 1.08% of the portfolio, ranked #23.
Hexavest first reported a position in PFE in Q2 2013 and has held it in 34 quarters since. The position peaked at $251M in Q4 2017. 2,803 funds tracked by Wall St. Rank hold PFE as of Q3 2021.
- Hexavest held 410,098 shares of Pfizer worth $17.6M as of Q3 2021.
- Hexavest sold 202,419 Pfizer shares in Q3 2021, an estimated $8.97M.
- Pfizer made up 1.08% of Hexavest's portfolio in Q3 2021, its #23 holding.
- Hexavest first reported a position in Pfizer in Q2 2013 and has held it in 34 quarters since.
- Hexavest's Pfizer position peaked at $251M in Q4 2017.
- 2,803 funds tracked by Wall St. Rank held Pfizer as of Q3 2021.
Based on Hexavest's 13F filing for Q3 2021, filed 27 Oct 2021.